Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Tipranavir |
Security Level |
|
Mechanism |
Tipranavir: May decrease the serum concentration of PHENobarbital. PHENobarbital may decrease the serum concentration of Tipranavir. |
Management |
Consider therapy modification |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Tipranavir
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Tipranavir Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of Tipranavir
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.